Skip to content

Does Post Operative Pancreatic Fistula, After Left Sided Resections, Heal Faster After the Introduction of a Pancreatic Stent?

Does a Pancreatic Stent Reduce the Healing Time of Post Operative Pancreatic Fistula (POPF) After Distal Pancreatic Resection - an Open Randomized Clinical Multicenter Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02220010
Enrollment
60
Registered
2014-08-19
Start date
2014-06-30
Completion date
2017-10-31
Last updated
2014-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healing Time of Post Operative Pancreatic Fistulas

Keywords

Post operative pancreatic fistulas, Pancreatic stenting

Brief summary

Dividing pancreas when performing left-sided resections opens the risk for leakage from the divided end of the pancreas. Pancreatic juices could have a severe effect on surrounding abdominal tissues with abscess formation producing systemic inflammation and potential lethal bleeding. Proper drainage of pancreatic juices is the primary treatment. Effective drainage reduces healing time. A pancreatic stent could theoretically improve the drainage of pancreatic juice into the duodenum and by this shorten the healing time still further. Pre operative prophylactic stenting of the pancreas before division of the parenchyma has not shown a positive effect on fistula formation. In an open randomized multicenter clinical trial we want to test the hypothesis that a reduced fistula healing time, in left sided pancreatic resections, could be reduced by introducing a pancreatic stent when on post operative day 3 or later a B och C fistula (according to the International Study Group on Pancreatic Fistula, ISGPF) is diagnosed by randomizing between pancreatic stent with drains versus only drains.

Interventions

The plastic stent is introduced in the pancreatic duct by a duodenoscope

Sponsors

Sahlgrenska University Hospital
CollaboratorOTHER
Lund University Hospital
CollaboratorOTHER
University Hospital, Linkoeping
CollaboratorOTHER
Norrlands University Hospital
CollaboratorOTHER
Karolinska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Signed informed consent * Left sided or distal pancreatic resection * Grade B or C fistula on postoperative day 3 or later

Exclusion criteria

* Do not want to participate in study * Can not read patient information in swedish * The papilla can not be endoscopically reached

Design outcomes

Primary

MeasureTime frameDescription
POPF healing time (days)12 days (median hospital stay)Post operative pancreatic fistula(POPF) and grade (A,B,C) is diagnosed according to ISGPF on post operative day 3 or later if the pancrease-amylase concentration is more than three times the upper limit of the normal plasma concentration of pancreas-amylase. When the drain fluid concentration is below this value the fistula is defined as healed.

Secondary

MeasureTime frameDescription
POPF grade (A,B,C)12 days (median hospital stay)International Study Group on Pancreatic Fistula (ISGPF) (Bassi et al 2005)defines fistula grade A-C. Grade A is leakage of pancreatic juice with a concentration of more than 3 times the upper normal level in plasma but no other clinical implication for the patient. If an inflammatory response is seen, but not sepsis, it is graded as B fistula and if sepsis occurs and/or single- or multi-organ dysfunction is seen it is graded as C.

Other

MeasureTime frameDescription
Blood chemistry12 days (median hospital stay)C-reactive protein, white blood cell count and pancreas amylase in plasma and drains
Morbidity12 days (median in hospital stay)Classification according to Clavien-Dindo
Mortality< 90 days after the operation
Hospital stay12 days (median hospital stay)Number of days in hospital

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026